Kevin Meli

PhD Candidate, Harvard University

Epigenomic State Transitions Characterize Tumor Progression in Mouse Lung Adenocarcinoma.


Journal article


Lindsay M. LaFave, Lindsay M. LaFave, Vinay K. Kartha, Sai Ma, Sai Ma, Sai Ma, Kevin Meli, Isabella Del Priore, Caleb Lareau, Caleb Lareau, Santiago Naranjo, Peter M.K. Westcott, Fabiana M. Duarte, Venkat Sankar, Venkat Sankar, Zachary Chiang, Alison Brack, Travis Law, Haley Hauck, Annalisa Okimoto, Aviv Regev, Aviv Regev, Jason D. Buenrostro, Jason D. Buenrostro, Tyler Jacks
Cancer Cell, vol. 38(2), 2020 Jul 9

Cite

Cite

APA   Click to copy
LaFave, L. M., LaFave, L. M., Kartha, V. K., Ma, S., Ma, S., Ma, S., … Jacks, T. (2020). Epigenomic State Transitions Characterize Tumor Progression in Mouse Lung Adenocarcinoma. Cancer Cell, 38(2).


Chicago/Turabian   Click to copy
LaFave, Lindsay M., Lindsay M. LaFave, Vinay K. Kartha, Sai Ma, Sai Ma, Sai Ma, Kevin Meli, et al. “Epigenomic State Transitions Characterize Tumor Progression in Mouse Lung Adenocarcinoma.” Cancer Cell 38, no. 2 (July 9, 2020).


MLA   Click to copy
LaFave, Lindsay M., et al. “Epigenomic State Transitions Characterize Tumor Progression in Mouse Lung Adenocarcinoma.” Cancer Cell, vol. 38, no. 2, July 2020.


BibTeX   Click to copy

@article{lindsay2020a,
  title = {Epigenomic State Transitions Characterize Tumor Progression in Mouse Lung Adenocarcinoma.},
  year = {2020},
  month = jul,
  day = {9},
  issue = {2},
  journal = {Cancer Cell},
  volume = {38},
  author = {LaFave, Lindsay M. and LaFave, Lindsay M. and Kartha, Vinay K. and Ma, Sai and Ma, Sai and Ma, Sai and Meli, Kevin and Priore, Isabella Del and Lareau, Caleb and Lareau, Caleb and Naranjo, Santiago and Westcott, Peter M.K. and Duarte, Fabiana M. and Sankar, Venkat and Sankar, Venkat and Chiang, Zachary and Brack, Alison and Law, Travis and Hauck, Haley and Okimoto, Annalisa and Regev, Aviv and Regev, Aviv and Buenrostro, Jason D. and Buenrostro, Jason D. and Jacks, Tyler},
  month_numeric = {7}
}


Share



Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in